<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000630970">
  <TermName>MDR modulator CBT-1</TermName>
  <TermPronunciation>(… MAH-juh-lay-ter …)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance taken from plants that is being studied in the treatment of cancer. It may help drugs kill tumor cells that have become resistant to drugs. It is a type of multidrug resistance inhibitor and a type of P-glycoprotein antagonist.  Also called CBT-1.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000722593" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;MDR modulator CBT-1&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000722594" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;modulador de RMF CBT-1&quot;" language="es" id="_4"/>
  <SpanishTermName>modulador de RMF CBT-1</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia que se extrae de las plantas y que está en estudio para el tratamiento del cáncer. Es posible que ayude a los medicamentos a destruir las células que se han vuelto resistentes. Es un tipo de antagonista de la glucoproteína P y de inhibidor de la resistencia que presentan algunas células a múltiples medicamentos. También se llama CBT-1.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2008-12-29</DateFirstPublished>
</GlossaryTerm>
